Canada markets open in 6 hours 49 minutes

Sensei Biotherapeutics, Inc. (SNSE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.6500+0.3800 (+29.92%)
At close: 04:00PM EDT
1.7200 +0.07 (+4.24%)
After hours: 07:55PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 41.37M
Enterprise Value -18.18M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.64
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.56

Trading Information

Stock Price History

Beta (5Y Monthly) 0.16
52-Week Change 3-22.70%
S&P500 52-Week Change 321.33%
52 Week High 31.9200
52 Week Low 30.5100
50-Day Moving Average 30.9861
200-Day Moving Average 30.8709

Share Statistics

Avg Vol (3 month) 382.77k
Avg Vol (10 day) 398.29k
Shares Outstanding 525.07M
Implied Shares Outstanding 625.07M
Float 816.41M
% Held by Insiders 134.63%
% Held by Institutions 110.55%
Shares Short (Apr 15, 2024) 481.03k
Short Ratio (Apr 15, 2024) 40.84
Short % of Float (Apr 15, 2024) 40.57%
Short % of Shares Outstanding (Apr 15, 2024) 40.32%
Shares Short (prior month Mar 15, 2024) 4145.86k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.97%
Return on Equity (ttm)-40.52%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -35.61M
Net Income Avi to Common (ttm)-34.1M
Diluted EPS (ttm)-1.2200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)65.76M
Total Cash Per Share (mrq)2.62
Total Debt (mrq)6.21M
Total Debt/Equity (mrq)9.57%
Current Ratio (mrq)11.92
Book Value Per Share (mrq)2.59

Cash Flow Statement

Operating Cash Flow (ttm)-32.02M
Levered Free Cash Flow (ttm)-21.32M